SlideShare a Scribd company logo
1 of 29
Pankaj Yadav
346/11
 Hepatitis B is a germ
(virus) that gets into
your body and attacks
your liver.
 Your liver helps your
body digest the food
you eat and store
energy. It also helps
your body get rid of
poisons
 Acute Hepatitis B
 In Acute Hepatitis B ,Most adults who get it have it
for a short time and then get better.
 Chronic Hepatitis B
 Sometimes the virus causes a long-term infection,
called chronic hepatitis.
 It is passed by contact with the blood or other
body fluids of someone who has the hepatitis
B virus.
 Being born to a mother who has hepatitis B.
 Sharing needles and syringes.
 The main symptoms are fatigue, abdominal
pain, and jaundice (yellow coloration of the
skin).
 Other symptoms may include
nausea/vomiting and joint pain
 Bloated or swollen stomach
Hepatitis A
 This form of hepatitis never leads to a
chronic infection and usually has no
complications.
Hepatitis C
 At least 80% of patients with hepatitis C
develop a chronic liver infection.
 No vaccine is yet available to prevent
hepatitis C.
 Approximately 1 in 12 persons worldwide, or
some 500 million people, are living with
chronic viral hepatitis .
 An estimated 350 million people are living
with chronic hepatitis B worldwide.
 An estimated 1 million people die each year
from hepatitis B and its complications.
 Chronic hepatitis C affects an estimated 170
million people worldwide and causes
approximately 350,000 deaths each year .
 Highest rate of people that get it are in the 20
to 49 year old age group.
 There has been a great decline in infected
children due to routine vaccinations.
 An estimated 1.25 million chronically infected
americans (20-30% get it in childhood).
 A member of the hepadnavirus group.
 Circular partially double-stranded DNA
viruses
 It has not yet been possible to propogate the
virus in cell culture.
 HBsAg
 HBcAg (HBeAg is a splice variant)
 Hepatitis B virus DNA polymerase(it convert
the viral RNA genome into dsDNA in viral
cytoplasmic capsids)
 It is developed for the prevention of hepatitis
B virus infection.
 The vaccine contains one of the viral envelope
proteins, hepatitis B surface antigen (HBsAg).
 It is produced by hansenula polymorpha
(yeast )cells, into which the genetic code for
HBsAg has been inserted
 The first vaccine became available in 1981.
 Paediatric
 Each dose of 0.5 ml
contains :
 10 mcg of purified Hepatitis
B surface antigen
 Adsorbed on Aluminium
hydroxide (Al+++)0.25 mg
to 0.40 mg
 Preservative: Thiomersal
0.025 mg
 Produced in Hansenula
Polymorpha (yeast)
 Dose : 0.5 ml by
intramuscular injection
 Adult
 Each dose of 1 ml contains :
 20 mcg of purified Hepatitis
B surface antigen
 Adsorbed on Aluminium
hydroxide (Al+++)0.5 mg
to 0.8 mg
 Preservative: Thiomersal
0.05 mg
 Produced in Hansenula
Polymorpha (yeast)
 Dose : 1 ml by
intramuscular injection
It can also cause long-term
(chronic) illness that leads to:
 Liver damage (cirrhosis)
 Liver cancer
Children and Adults
 Babies normally get 3 doses of hepatitis B
vaccine:
 1st Dose: Birth
 2nd Dose: 1-2 months of age
 3rd Dose: 6-18 months of age
 Everyone 18 years of age and younger.
 Adults over 18 who are at risk.
 People with life-threatening allergic reaction
to baker’s yeast or to hepatitis B vaccine.
 People with moderate or severe illness should
wait until they recover.
 Severe allergic reactions, harm or death
(extremely rare).
 Soreness at site of injection lasting 1-2 days.
 Mild to moderate fever.
 Hives, swelling, redness
 High fever
 Difficulty breathing, wheezing
 Dizzyness
 When to expect an allergic
reaction?
 Within a few minutes to a few hours after the shot.
 What should I do?
 CALL a doctor or see a doctor right away.
 There are 3 common tests.
 HBsAg, HBsAb, HBcAb.
 The doctor needs all 3 blood test results in
order to determine your diagnosis.
 The hepatitis B blood panel requires only
one blood sample but includes three tests.
 HBsAg (hepatitis B surface antigen)
 HBsAb or Anti-HBs (hepatitis B surface
antibody)
 HBcAb or anti-HBc (hepatitis B core antibody)
 This test looks for hepatitis B surface
antigens in your blood.
 A "positive" or "reactive" HBsAg test result
means that the person is infected with the
hepatitis B virus.
 A "positive" or "reactive" HBsAb (or anti-HBs)
test result indicates that a person has
successfully responded to the hepatitis B
vaccine or has recovered from an acute
hepatitis B infection.
 This result means that you are immune to
future hepatitis B infection and you are not
contagious.
 The HBcAb is an antibody that is part of the
virus- it does not provide protection.
 Test result indicates a past or present
infection, but it could also be a false positive.
 Hepatitis B is a leading cause of death
worldwide and the primary cause of hepatic
cirrhosis.
 Available evidence indicates that control of
Hepatitis B replication with antiviral therapy
decreases the incidence of complications.
Thank You…

More Related Content

What's hot

Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitis
Raeez Basheer
 
Update on Chronic Hepatitis B
Update on Chronic Hepatitis BUpdate on Chronic Hepatitis B
Update on Chronic Hepatitis B
drnkhokhar
 

What's hot (20)

Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis c.diagnosis and management
Hepatitis c.diagnosis and managementHepatitis c.diagnosis and management
Hepatitis c.diagnosis and management
 
Aasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis bAasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis b
 
Hepatitis b (hbv)
Hepatitis b (hbv)Hepatitis b (hbv)
Hepatitis b (hbv)
 
Hepatitis virus
Hepatitis virusHepatitis virus
Hepatitis virus
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Viral hepatitis B and C
Viral hepatitis B and CViral hepatitis B and C
Viral hepatitis B and C
 
Hepatitis B, Viral Hepatitis
Hepatitis B, Viral HepatitisHepatitis B, Viral Hepatitis
Hepatitis B, Viral Hepatitis
 
what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitis
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis (viral and non viral types) ppt slideshare
Hepatitis (viral and non viral types) ppt slideshareHepatitis (viral and non viral types) ppt slideshare
Hepatitis (viral and non viral types) ppt slideshare
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
 
Complete Blood Count, Interpretations
Complete Blood Count, InterpretationsComplete Blood Count, Interpretations
Complete Blood Count, Interpretations
 
Update on Chronic Hepatitis B
Update on Chronic Hepatitis BUpdate on Chronic Hepatitis B
Update on Chronic Hepatitis B
 
Viral Hepatitis
Viral HepatitisViral Hepatitis
Viral Hepatitis
 
Interpretation of cbc
Interpretation of cbcInterpretation of cbc
Interpretation of cbc
 

Viewers also liked

Enfermedades de transmision sexual presentación de microsoft office power point
Enfermedades de transmision sexual presentación de microsoft office power pointEnfermedades de transmision sexual presentación de microsoft office power point
Enfermedades de transmision sexual presentación de microsoft office power point
awadecoco
 
Hepatitis viral (A,B,C,D,E,F,G) (2012)
Hepatitis viral (A,B,C,D,E,F,G)  (2012) Hepatitis viral (A,B,C,D,E,F,G)  (2012)
Hepatitis viral (A,B,C,D,E,F,G) (2012)
Eric Ardiles
 

Viewers also liked (16)

Hepatitis Presentation
Hepatitis PresentationHepatitis Presentation
Hepatitis Presentation
 
Nitrogen fixation -
Nitrogen fixation - Nitrogen fixation -
Nitrogen fixation -
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Enfermedades de transmision sexual presentación de microsoft office power point
Enfermedades de transmision sexual presentación de microsoft office power pointEnfermedades de transmision sexual presentación de microsoft office power point
Enfermedades de transmision sexual presentación de microsoft office power point
 
NITROGEN CYCLE AND FIXATION
NITROGEN CYCLE AND FIXATIONNITROGEN CYCLE AND FIXATION
NITROGEN CYCLE AND FIXATION
 
Nitrogen cycle ppt
Nitrogen cycle pptNitrogen cycle ppt
Nitrogen cycle ppt
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Presentación HEPATITIS B
Presentación HEPATITIS BPresentación HEPATITIS B
Presentación HEPATITIS B
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
 
Nitrogen fixation
Nitrogen fixationNitrogen fixation
Nitrogen fixation
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Hepatitis
Hepatitis Hepatitis
Hepatitis
 
Hepatitis viral (A,B,C,D,E,F,G) (2012)
Hepatitis viral (A,B,C,D,E,F,G)  (2012) Hepatitis viral (A,B,C,D,E,F,G)  (2012)
Hepatitis viral (A,B,C,D,E,F,G) (2012)
 

Similar to Ppt on hepatitis b

viral hepatitis in children its types .pptx
viral hepatitis in children its types .pptxviral hepatitis in children its types .pptx
viral hepatitis in children its types .pptx
Shibili Abraham
 
Hepatitis
HepatitisHepatitis
Hepatitis
dorai
 
Hepatitis
HepatitisHepatitis
Hepatitis
dorai
 
Hepatitis in english
Hepatitis in englishHepatitis in english
Hepatitis in english
MY STUDENT SUPPORT SYSTEM .
 

Similar to Ppt on hepatitis b (20)

Hepatitis b virus (hbv) infection a silent epidemic
Hepatitis b virus (hbv) infection a silent epidemicHepatitis b virus (hbv) infection a silent epidemic
Hepatitis b virus (hbv) infection a silent epidemic
 
Hepatitis B
Hepatitis B Hepatitis B
Hepatitis B
 
viral hepatitis in children its types .pptx
viral hepatitis in children its types .pptxviral hepatitis in children its types .pptx
viral hepatitis in children its types .pptx
 
Approach to newly detected hep b
Approach to newly detected hep b Approach to newly detected hep b
Approach to newly detected hep b
 
what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)
 
Hepatitis B Virus (hbv)
Hepatitis B Virus (hbv)Hepatitis B Virus (hbv)
Hepatitis B Virus (hbv)
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
3.chronic infection
3.chronic infection3.chronic infection
3.chronic infection
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
viral hepatitis .docx
viral hepatitis .docxviral hepatitis .docx
viral hepatitis .docx
 
Update on Prevalence, Diagnosis, and Treatment of HBV (PPT Thesis)
Update on Prevalence, Diagnosis, and Treatment of HBV (PPT Thesis)Update on Prevalence, Diagnosis, and Treatment of HBV (PPT Thesis)
Update on Prevalence, Diagnosis, and Treatment of HBV (PPT Thesis)
 
Hepatitis b,c, &d
Hepatitis b,c, &dHepatitis b,c, &d
Hepatitis b,c, &d
 
HEPATITIS IN CHILDREN
HEPATITIS IN CHILDRENHEPATITIS IN CHILDREN
HEPATITIS IN CHILDREN
 
hepatitis-200829153432 (1).pdf
hepatitis-200829153432 (1).pdfhepatitis-200829153432 (1).pdf
hepatitis-200829153432 (1).pdf
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Hepatitis in english
Hepatitis in englishHepatitis in english
Hepatitis in english
 
VIRAL HEPATITIS by NOM KUMAR NAIK
VIRAL HEPATITIS  by NOM KUMAR NAIKVIRAL HEPATITIS  by NOM KUMAR NAIK
VIRAL HEPATITIS by NOM KUMAR NAIK
 
VIRAL HEPATITIS, RISK FACTORS AND MANAGEMENT.pptx
VIRAL HEPATITIS, RISK FACTORS AND MANAGEMENT.pptxVIRAL HEPATITIS, RISK FACTORS AND MANAGEMENT.pptx
VIRAL HEPATITIS, RISK FACTORS AND MANAGEMENT.pptx
 

Recently uploaded

Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills KuwaitKuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
jaanualu31
 
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
ssuser89054b
 
notes on Evolution Of Analytic Scalability.ppt
notes on Evolution Of Analytic Scalability.pptnotes on Evolution Of Analytic Scalability.ppt
notes on Evolution Of Analytic Scalability.ppt
MsecMca
 

Recently uploaded (20)

Bridge Jacking Design Sample Calculation.pptx
Bridge Jacking Design Sample Calculation.pptxBridge Jacking Design Sample Calculation.pptx
Bridge Jacking Design Sample Calculation.pptx
 
FEA Based Level 3 Assessment of Deformed Tanks with Fluid Induced Loads
FEA Based Level 3 Assessment of Deformed Tanks with Fluid Induced LoadsFEA Based Level 3 Assessment of Deformed Tanks with Fluid Induced Loads
FEA Based Level 3 Assessment of Deformed Tanks with Fluid Induced Loads
 
Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills KuwaitKuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
Kuwait City MTP kit ((+919101817206)) Buy Abortion Pills Kuwait
 
A Study of Urban Area Plan for Pabna Municipality
A Study of Urban Area Plan for Pabna MunicipalityA Study of Urban Area Plan for Pabna Municipality
A Study of Urban Area Plan for Pabna Municipality
 
2016EF22_0 solar project report rooftop projects
2016EF22_0 solar project report rooftop projects2016EF22_0 solar project report rooftop projects
2016EF22_0 solar project report rooftop projects
 
Hazard Identification (HAZID) vs. Hazard and Operability (HAZOP): A Comparati...
Hazard Identification (HAZID) vs. Hazard and Operability (HAZOP): A Comparati...Hazard Identification (HAZID) vs. Hazard and Operability (HAZOP): A Comparati...
Hazard Identification (HAZID) vs. Hazard and Operability (HAZOP): A Comparati...
 
A CASE STUDY ON CERAMIC INDUSTRY OF BANGLADESH.pptx
A CASE STUDY ON CERAMIC INDUSTRY OF BANGLADESH.pptxA CASE STUDY ON CERAMIC INDUSTRY OF BANGLADESH.pptx
A CASE STUDY ON CERAMIC INDUSTRY OF BANGLADESH.pptx
 
kiln thermal load.pptx kiln tgermal load
kiln thermal load.pptx kiln tgermal loadkiln thermal load.pptx kiln tgermal load
kiln thermal load.pptx kiln tgermal load
 
HOA1&2 - Module 3 - PREHISTORCI ARCHITECTURE OF KERALA.pptx
HOA1&2 - Module 3 - PREHISTORCI ARCHITECTURE OF KERALA.pptxHOA1&2 - Module 3 - PREHISTORCI ARCHITECTURE OF KERALA.pptx
HOA1&2 - Module 3 - PREHISTORCI ARCHITECTURE OF KERALA.pptx
 
Minimum and Maximum Modes of microprocessor 8086
Minimum and Maximum Modes of microprocessor 8086Minimum and Maximum Modes of microprocessor 8086
Minimum and Maximum Modes of microprocessor 8086
 
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in South Ex (delhi) call me [🔝9953056974🔝] escort service 24X7
 
Thermal Engineering -unit - III & IV.ppt
Thermal Engineering -unit - III & IV.pptThermal Engineering -unit - III & IV.ppt
Thermal Engineering -unit - III & IV.ppt
 
Rums floating Omkareshwar FSPV IM_16112021.pdf
Rums floating Omkareshwar FSPV IM_16112021.pdfRums floating Omkareshwar FSPV IM_16112021.pdf
Rums floating Omkareshwar FSPV IM_16112021.pdf
 
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
 
AIRCANVAS[1].pdf mini project for btech students
AIRCANVAS[1].pdf mini project for btech studentsAIRCANVAS[1].pdf mini project for btech students
AIRCANVAS[1].pdf mini project for btech students
 
notes on Evolution Of Analytic Scalability.ppt
notes on Evolution Of Analytic Scalability.pptnotes on Evolution Of Analytic Scalability.ppt
notes on Evolution Of Analytic Scalability.ppt
 
S1S2 B.Arch MGU - HOA1&2 Module 3 -Temple Architecture of Kerala.pptx
S1S2 B.Arch MGU - HOA1&2 Module 3 -Temple Architecture of Kerala.pptxS1S2 B.Arch MGU - HOA1&2 Module 3 -Temple Architecture of Kerala.pptx
S1S2 B.Arch MGU - HOA1&2 Module 3 -Temple Architecture of Kerala.pptx
 
data_management_and _data_science_cheat_sheet.pdf
data_management_and _data_science_cheat_sheet.pdfdata_management_and _data_science_cheat_sheet.pdf
data_management_and _data_science_cheat_sheet.pdf
 
Engineering Drawing focus on projection of planes
Engineering Drawing focus on projection of planesEngineering Drawing focus on projection of planes
Engineering Drawing focus on projection of planes
 
Generative AI or GenAI technology based PPT
Generative AI or GenAI technology based PPTGenerative AI or GenAI technology based PPT
Generative AI or GenAI technology based PPT
 

Ppt on hepatitis b

  • 2.  Hepatitis B is a germ (virus) that gets into your body and attacks your liver.  Your liver helps your body digest the food you eat and store energy. It also helps your body get rid of poisons
  • 3.  Acute Hepatitis B  In Acute Hepatitis B ,Most adults who get it have it for a short time and then get better.  Chronic Hepatitis B  Sometimes the virus causes a long-term infection, called chronic hepatitis.
  • 4.  It is passed by contact with the blood or other body fluids of someone who has the hepatitis B virus.  Being born to a mother who has hepatitis B.  Sharing needles and syringes.
  • 5.  The main symptoms are fatigue, abdominal pain, and jaundice (yellow coloration of the skin).  Other symptoms may include nausea/vomiting and joint pain  Bloated or swollen stomach
  • 6. Hepatitis A  This form of hepatitis never leads to a chronic infection and usually has no complications. Hepatitis C  At least 80% of patients with hepatitis C develop a chronic liver infection.  No vaccine is yet available to prevent hepatitis C.
  • 7.  Approximately 1 in 12 persons worldwide, or some 500 million people, are living with chronic viral hepatitis .  An estimated 350 million people are living with chronic hepatitis B worldwide.  An estimated 1 million people die each year from hepatitis B and its complications.  Chronic hepatitis C affects an estimated 170 million people worldwide and causes approximately 350,000 deaths each year .
  • 8.  Highest rate of people that get it are in the 20 to 49 year old age group.  There has been a great decline in infected children due to routine vaccinations.  An estimated 1.25 million chronically infected americans (20-30% get it in childhood).
  • 9.
  • 10.
  • 11.  A member of the hepadnavirus group.  Circular partially double-stranded DNA viruses  It has not yet been possible to propogate the virus in cell culture.
  • 12.
  • 13.  HBsAg  HBcAg (HBeAg is a splice variant)  Hepatitis B virus DNA polymerase(it convert the viral RNA genome into dsDNA in viral cytoplasmic capsids)
  • 14.  It is developed for the prevention of hepatitis B virus infection.  The vaccine contains one of the viral envelope proteins, hepatitis B surface antigen (HBsAg).  It is produced by hansenula polymorpha (yeast )cells, into which the genetic code for HBsAg has been inserted  The first vaccine became available in 1981.
  • 15.  Paediatric  Each dose of 0.5 ml contains :  10 mcg of purified Hepatitis B surface antigen  Adsorbed on Aluminium hydroxide (Al+++)0.25 mg to 0.40 mg  Preservative: Thiomersal 0.025 mg  Produced in Hansenula Polymorpha (yeast)  Dose : 0.5 ml by intramuscular injection  Adult  Each dose of 1 ml contains :  20 mcg of purified Hepatitis B surface antigen  Adsorbed on Aluminium hydroxide (Al+++)0.5 mg to 0.8 mg  Preservative: Thiomersal 0.05 mg  Produced in Hansenula Polymorpha (yeast)  Dose : 1 ml by intramuscular injection
  • 16. It can also cause long-term (chronic) illness that leads to:  Liver damage (cirrhosis)  Liver cancer
  • 17. Children and Adults  Babies normally get 3 doses of hepatitis B vaccine:  1st Dose: Birth  2nd Dose: 1-2 months of age  3rd Dose: 6-18 months of age
  • 18.  Everyone 18 years of age and younger.  Adults over 18 who are at risk.
  • 19.  People with life-threatening allergic reaction to baker’s yeast or to hepatitis B vaccine.  People with moderate or severe illness should wait until they recover.
  • 20.  Severe allergic reactions, harm or death (extremely rare).  Soreness at site of injection lasting 1-2 days.  Mild to moderate fever.
  • 21.  Hives, swelling, redness  High fever  Difficulty breathing, wheezing  Dizzyness
  • 22.  When to expect an allergic reaction?  Within a few minutes to a few hours after the shot.  What should I do?  CALL a doctor or see a doctor right away.
  • 23.  There are 3 common tests.  HBsAg, HBsAb, HBcAb.  The doctor needs all 3 blood test results in order to determine your diagnosis.  The hepatitis B blood panel requires only one blood sample but includes three tests.
  • 24.  HBsAg (hepatitis B surface antigen)  HBsAb or Anti-HBs (hepatitis B surface antibody)  HBcAb or anti-HBc (hepatitis B core antibody)
  • 25.  This test looks for hepatitis B surface antigens in your blood.  A "positive" or "reactive" HBsAg test result means that the person is infected with the hepatitis B virus.
  • 26.  A "positive" or "reactive" HBsAb (or anti-HBs) test result indicates that a person has successfully responded to the hepatitis B vaccine or has recovered from an acute hepatitis B infection.  This result means that you are immune to future hepatitis B infection and you are not contagious.
  • 27.  The HBcAb is an antibody that is part of the virus- it does not provide protection.  Test result indicates a past or present infection, but it could also be a false positive.
  • 28.  Hepatitis B is a leading cause of death worldwide and the primary cause of hepatic cirrhosis.  Available evidence indicates that control of Hepatitis B replication with antiviral therapy decreases the incidence of complications.

Editor's Notes

  1. Hepatitis B vaccine can prevent hepatitis B, and the serious consequences of hepatitis B infection, including liver cancer and cirrhosis. Hepatitis B vaccine may be given by itself or in the same shot with other vaccines. Routine hepatitis B vaccination was recommended for some U.S. adults and children beginning in 1982, and for all children in 1991. Since 1990, new hepatitis B infections among children and adolescents have dropped by more than 95% – and by 75% in other age groups. Vaccination gives long-term protection from hepatitis B infection, possibly lifelong.
  2. HBV is a leading cause of death worldwide and the primary cause of hepatic cirrhosis and HCC. Chronic HBV infection is an increasingly important public health problem. The natural history of chronic HBV infection is determined to a large extent by the level of HBV replication, as reflected in circulating levels of HBV DNA in serum. Available evidence indicates that control of HBV replication with antiviral therapy decreases the incidence of complications. Individuals with chronic hepatitis B require regular monitoring for viral activity, viral load reduction, drug resistance, and disease progression. Enhanced understanding of viral, host, and environmental factors that influence disease progression may ultimately improve the management of patients with chronic HBV infection. Ideally, prevention of hepatitis B through global vaccination programs and routinely applied neonatal and primary adulthood prophylaxis should be pursued